Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Yes, fluoxetine (Prozac) carries an FDA boxed warning because it can increase suicidal thoughts and behaviors, most often in children, teens, and adults under 25, and usually within the first few weeks of starting treatment or after a dose change. Call your doctor right away if you notice new or worsening suicidal thoughts, self-harm urges, severe agitation, panic, aggression, impulsivity, insomnia, or an unusually elevated mood, and seek emergency care or call or text 988 if you feel unsafe now. Other urgent reasons to call include signs of serotonin syndrome, such as confusion, rapid heartbeat, fever, muscle stiffness, or tremor, plus unusual bleeding or a rash. Never stop fluoxetine abruptly on your own, since tapering decisions and monitoring schedules depend on your age, diagnosis, and other medications. There are several important factors and warning signs to weigh, so see below to understand more.
Because these symptoms can overlap with worsening depression, medication side effects, or another condition entirely, it helps to organize what you are feeling before you pick up the phone. A free, instant, online symptom check can help you clarify your symptoms, understand possible causes, and see which next steps and level of care make the most sense right now.
Last reviewed for medical accuracy: 09/12/2026
Fluoxetine is a widely prescribed antidepressant in the selective serotonin reuptake inhibitor (SSRI) class. It’s commonly used to treat major depressive disorder, obsessive-compulsive disorder, bulimia nervosa, panic disorder and other conditions. While fluoxetine can be highly effective, it carries a boxed warning about an increased risk of suicidal thoughts and behaviors, especially in certain age groups. Understanding these risks and knowing when to seek medical help can keep you—or someone you care for—safe.
Regulatory agencies require all antidepressants, including fluoxetine, to carry a warning that in some users, particularly younger people, treatment may trigger or worsen suicidal thoughts.
If you or someone you care for is taking fluoxetine, watch for any new or worsening behaviors. Key warning signs include:
Keep a daily journal of mood and behavior changes—this can help your doctor track patterns and make timely decisions about your treatment.
Contact your prescribing physician or a mental health professional if you notice:
If you suspect that you or someone else may act on suicidal thoughts or if life-threatening symptoms occur, do not wait. Call emergency services (for example, 911 in the U.S.) or go to the nearest emergency department.
For additional peace of mind, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Fluoxetine has helped millions of people reclaim their lives from depression and other psychiatric conditions. Most users tolerate it well, and only a small percentage experience severe side effects or suicidal thinking. Still, staying informed and vigilant during the early weeks of treatment is crucial.
Never hesitate to reach out to a healthcare professional about any serious or life-threatening symptoms. If you or someone you know experiences suicidal thoughts or behaviors in association with fluoxetine—or for any other reason—seek medical help immediately.
This information is based on current medical guidelines and reputable sources. Always follow your doctor’s instructions and report any concerning symptoms without delay.
(References)
* Finnegan KT, Gabiola JM. Fluoxetine overdose. Am J Psychiatry. 1988 Dec;145(12):1604. doi: 10.1176/ajp.145.12.1604b. PMID: 3264119.
* Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ. 1995 Jan 28;310(6974):215-8. doi: 10.1136/bmj.310.6974.215. PMID: 7677826; PMCID: PMC2548617.
* Leroi I, Walentynowicz MA. Fluoxetine-imipramine interaction. Can J Psychiatry. 1996 Jun;41(5):318-9. doi: 10.1177/070674379604100515. PMID: 8793156.
* Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006 Mar;63(3):332-9. doi: 10.1001/archpsyc.63.3.332. PMID: 16520440.
* March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry. 2007 Oct;64(10):1132-43. doi: 10.1001/archpsyc.64.10.1132. PMID: 17909125.
* Zhou X, Teng T, Zhang Y, Del Giovane C, Furukawa TA, Weisz JR, Li X, Cuijpers P, Coghill D, Xiang Y, Hetrick SE, Leucht S, Qin M, Barth J, Ravindran AV, Yang L, Curry J, Fan L, Silva SG, Cipriani A, Xie P. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry. 2020 Jul;7(7):581-601. doi: 10.1016/S2215-0366(20)30137-1. PMID: 32563306; PMCID: PMC7303954.
* Boaden K, Tomlinson A, Cortese S, Cipriani A. Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerability and Suicidality in Acute Treatment. Front Psychiatry. 2020;11:717. doi: 10.3389/fpsyt.2020.00717. Epub 2020 Sep 2. PMID: 32982805; PMCID: PMC7493620.
* Hetrick SE, McKenzie JE, Bailey AP, Sharma V, Moller CI, Badcock PB, Cox GR, Merry SN, Meader N. New generation antidepressants for depression in children and adolescents: a network meta-analysis. Cochrane Database Syst Rev. 2021 May 24;5(5):CD013674. doi: 10.1002/14651858.CD013674.pub2. Epub 2021 May 24. PMID: 34029378; PMCID: PMC8143444.
* Attia E, Walsh BT. Eating Disorders: A Review. JAMA. 2025 Apr 8;333(14):1242-1252. doi: 10.1001/jama.2025.0132. PMID: 40048192.
* Del Casale A, Spirito S, Arena JF, Preissner S, Borro M, Gentile G, Modesti MN, Preissner R, Ferracuti S, Simmaco M. Esketamine Combined With SSRI or SNRI for Treatment-Resistant Depression. JAMA Psychiatry. 2025 Aug 1;82(8):810-817. doi: 10.1001/jamapsychiatry.2025.0200. PMID: 40172868; PMCID: PMC11966478.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.